NL-OMON44666已完成不适用
Clonidine Augmentation Treatment in Schizophrenia - CATS-Study
niversitair Medisch Centrum Utrecht0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •1. A DSM-IV-R diagnosis of: 295.x (schizophrenia), schizophreniform disorder, or schizoaffective disorder)
- •3. A total PANSS score of at least 55
- •4. Age 18-50 years.
- •5. Patients are treated with antipsychotic medication
- •6. Written informed consent
- •7. Female patients of childbearing potential need to utilize a proper method of contraception
- •8. (oral anticonceptives, vaginal ring, hormonal patch, intrauterine device, cervical cap, condom, contraceptive injection, diaphragm) in case of sexual intercourse during the study.
- •Ad. A priority will be given to patients who achieve no or only partial response to clozapine as defined by a total PANSS score of at least 80.;Inclusion criteria healthy controls:
- •-Age between 18-50 years
- •-Good Physical and Mental Health meeting criteria never mentally ill, which will be evaluated with a medical history checklist;
- •-Age between 18 and 45 years;
- •-Written informed consent of the subject.
排除标准
- •1. Presence of any of the contra-indications of clonidine as reported in the Summary of Product Characteristics (SPC).
- •2. Supine systolic blood pressure (SSBP) < 85 mm HG
- •3. Pre-existent orthostatic hypotension with a drop of systolic blood pressure of > 20 mmHg or a drop of diastolic blood pressure of >10 mmHg.
- •4. Supine heart rate (SHR) < 50 beats/min
- •5. Severe brady-arhytmias such as sick-sinussyndroom, second or third degree AV-block.
- •6. Pregnancy or breast-feeding. A urine pregnancy test will be performed at screening.
- •7. The use of drugs that affect the (nor)adrenergic system such as beta-blockes and mirtazapine.;Exclusion criteria healthy controls:
- •-Current use of any medication prescribed medication exclusive oral anticonceptives;
- •-Any subject who has received any investigational medication within 30 days prior to the start of this study;
- •-History of neurologic illness; History of psychiatric illness in first-degree relatives, evaluated with DSM-IV criteria;
- •-History of alcohol and drug abuse;
- •-BMI below 18.5.
研究者
相似试验
尚未招募
不适用
Clonidine: een veelbelovende toevoeging aan de huidige behandeling van schizofrenie.Therapy resistant schizophreniaClonidineNoradrenalineNL-OMON20882niversitair Medisch Centrum Utrecht75
进行中(未招募)
不适用
Clonidine added to the current treatment of therapy resistant schizophreniaSchizophrenia, schizophreniform disorder, schizoaffective disorderEUCTR2014-003008-53-NLniversity Medical Center Utrecht75
终止
3 期
Augmentation of antipsychotic medication with anticonvulsant in the management of treatment resistant schizophreniaMental and Behavioural DisordersSchizophreniaISRCTN77257074King's College London371
已完成
4 期
Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant SchizophreniaSchizophrenic DisordersPsychotic DisorderSchizophreniaNCT01279213Universidad Nacional de Rosario70
尚未招募
不适用
Investigating the effectiveness of adding Clonidine and Gabapentin to Buprenorphine during detoxification of children and adolescents with Opioid Use DisordersIRCT20110411006168N4Kerman University of Medical Sciences40
